Ishikawa T - Search Results

1

Blue-dye technique complements four-node sampling for early breast cancer.

Ishikawa T, Momiyama N, Hamaguchi Y, Tanabe M, Tomita S, Ichikawa Y, Nakatani Y, Sasaki T, Nozawa A, Inayama Y, Inui K, Shimada H. Ishikawa T, et al. Eur J Surg Oncol. 2005 Dec;31(10):1119-24. doi: 10.1016/j.ejso.2005.04.013. Epub 2005 Jul 7. Eur J Surg Oncol. 2005. PMID: 16005597

2

Transcription-reverse transcription concerted reaction and minimal residual disease in axillary sentinel nodes of breast cancer.

Ishikawa T, Miyajima E, Sasaki T, Tanabe M, Matsumoto C, Nozawa A, Kawachi K, Fukuno Y, Takeda H, Hayashi T, Onaka S, Momiyama N, Ichikawa Y, Inui K, Shimada H. Ishikawa T, et al. Eur J Surg Oncol. 2007 May;33(4):430-4. doi: 10.1016/j.ejso.2006.09.038. Epub 2006 Nov 13. Eur J Surg Oncol. 2007. PMID: 17101257

3

Pathological examination with two-millimetre serial sectioning for sentinel lymph node biopsies in breast cancer.

Ishikawa T, Sasaki T, Miyajima E, Shimizu D, Nozawa A, Kawachi K, Takase A, Miyazaki N, Tomioka R, Kikuchi M, Amari Y, Fukuno Y, Takeda H, Hayashi T, Onaka S, Ichikawa Y, Shimada H. Ishikawa T, et al. Eur J Surg Oncol. 2009 Aug;35(8):895-6. doi: 10.1016/j.ejso.2008.10.008. Epub 2008 Nov 20. Eur J Surg Oncol. 2009. PMID: 19022614

4

Observational study of blue dye-assisted four-node sampling for axillary staging in early breast cancer.

Narui K, Ishikawa T, Kito A, Shimizu D, Chishima T, Momiyama N, Ichikawa Y, Sasaki T, Nozawa A, Inayama Y, Shimada H, Endo I. Narui K, et al. Among authors: ishikawa t. Eur J Surg Oncol. 2010 Aug;36(8):731-6. doi: 10.1016/j.ejso.2010.06.011. Epub 2010 Jul 7. Eur J Surg Oncol. 2010. PMID: 20609549

5

A prospective feasibility study of sentinel node biopsy by modified Indigocarmine blue dye methods after neoadjuvant chemotherapy for breast cancer.

Kida K, Ishikawa T, Yamada A, Shimizu D, Tanabe M, Sasaki T, Ichikawa Y, Endo I. Kida K, et al. Among authors: ishikawa t. Eur J Surg Oncol. 2015 Apr;41(4):566-70. doi: 10.1016/j.ejso.2014.10.066. Epub 2015 Jan 22. Eur J Surg Oncol. 2015. PMID: 25650249 Clinical Trial.

6

Outcomes of immediate perforator flap reconstruction after skin-sparing mastectomy following neoadjuvant chemotherapy.

Narui K, Ishikawa T, Satake T, Adachi S, Yamada A, Shimada K, Shimizu D, Kida K, Sugae S, Ichikawa Y, Tanabe M, Sasaki T, Endo I. Narui K, et al. Among authors: ishikawa t. Eur J Surg Oncol. 2015 Jan;41(1):94-9. doi: 10.1016/j.ejso.2014.09.001. Epub 2014 Sep 9. Eur J Surg Oncol. 2015. PMID: 25245538

7

BRCAness is beneficial for indicating triple negative breast cancer patients resistant to taxane.

Ishikawa T, Narui K, Tanabe M, Kida K, Oba MS, Yamada A, Ichikawa Y, Endo I. Ishikawa T, et al. Eur J Surg Oncol. 2016 Jul;42(7):999-1001. doi: 10.1016/j.ejso.2016.02.246. Epub 2016 Mar 2. Eur J Surg Oncol. 2016. PMID: 27041672 Clinical Trial.

8

Detection of regional lymph node metastases in colon cancer by using RT-PCR for matrix metalloproteinase 7, matrilysin.

Ichikawa Y, Ishikawa T, Momiyama N, Yamaguchi S, Masui H, Hasegawa S, Chishima T, Takimoto A, Kitamura H, Akitaya T, Hosokawa T, Mitsuhashi M, Shimada H. Ichikawa Y, et al. Among authors: ishikawa t. Clin Exp Metastasis. 1998 Jan;16(1):3-8. doi: 10.1023/a:1006576032722. Clin Exp Metastasis. 1998. PMID: 9502072

9

Donor site selection and clinical outcomes of nipple-areola skin-sparing mastectomy with immediate autologous free flap reconstruction: A single-institution experience.

Fujimoto H, Ishikawa T, Satake T, Ko S, Shimizu D, Narui K, Yamada A, Sasaki T, Nagashima T, Endo I, Miyazaki M. Fujimoto H, et al. Among authors: ishikawa t. Eur J Surg Oncol. 2016 Mar;42(3):369-75. doi: 10.1016/j.ejso.2015.12.002. Epub 2015 Dec 29. Eur J Surg Oncol. 2016. PMID: 26792708

10

Matrilysin as a target for chemotherapy for colon cancer: use of antisense oligonucleotides as antimetastatic agents.

Miyazaki K, Koshikawa N, Hasegawa S, Momiyama N, Nagashima Y, Moriyama K, Ichikawa Y, Ishikawa T, Mitsuhashi M, Shimada H. Miyazaki K, et al. Among authors: ishikawa t. Cancer Chemother Pharmacol. 1999;43 Suppl:S52-5. doi: 10.1007/s002800051098. Cancer Chemother Pharmacol. 1999. PMID: 10357559 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,642 results

Search Page